FI961439A - Menetelmä terapeuttisesti käyttökelpoisen vasta-aineen tai vasta-ainefragmentin valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisen vasta-aineen tai vasta-ainefragmentin valmistamiseksi Download PDF

Info

Publication number
FI961439A
FI961439A FI961439A FI961439A FI961439A FI 961439 A FI961439 A FI 961439A FI 961439 A FI961439 A FI 961439A FI 961439 A FI961439 A FI 961439A FI 961439 A FI961439 A FI 961439A
Authority
FI
Finland
Prior art keywords
antibody
fragment
therapeutically useful
producing
useful
Prior art date
Application number
FI961439A
Other languages
English (en)
Swedish (sv)
Other versions
FI103477B1 (fi
FI961439A0 (fi
FI103477B (fi
Inventor
Peter S Mezes
Brian B Gourlie
Mark W Rixon
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1989/004402 external-priority patent/WO1990004410A1/en
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of FI961439A publication Critical patent/FI961439A/fi
Publication of FI961439A0 publication Critical patent/FI961439A0/fi
Application granted granted Critical
Publication of FI103477B1 publication Critical patent/FI103477B1/fi
Publication of FI103477B publication Critical patent/FI103477B/fi

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI961439A 1988-10-19 1996-03-29 Menetelmä terapeuttisesti käyttökelpoisen vasta-aineen tai vasta-ainef ragmentin valmistamiseksi FI103477B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25994388A 1988-10-19 1988-10-19
US25994388 1988-10-19
PCT/US1989/004402 WO1990004410A1 (en) 1988-10-19 1989-10-04 A novel family of high affinity, modified antibodies for cancer treatment
US8904402 1989-10-04
FI903056 1990-06-18
FI903056A FI103181B (fi) 1988-10-19 1990-06-18 Uusi vasta-aine ja siihen liittyvät vasta-ainekonjugaatit, DNA-sekvens sit, ilmentämisvehikkelit ja solut

Publications (4)

Publication Number Publication Date
FI961439A true FI961439A (fi) 1996-03-29
FI961439A0 FI961439A0 (fi) 1996-03-29
FI103477B1 FI103477B1 (fi) 1999-07-15
FI103477B FI103477B (fi) 1999-07-15

Family

ID=26158772

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961439A FI103477B (fi) 1988-10-19 1996-03-29 Menetelmä terapeuttisesti käyttökelpoisen vasta-aineen tai vasta-ainef ragmentin valmistamiseksi

Country Status (1)

Country Link
FI (1) FI103477B (fi)

Also Published As

Publication number Publication date
FI103477B1 (fi) 1999-07-15
FI961439A0 (fi) 1996-03-29
FI103477B (fi) 1999-07-15

Similar Documents

Publication Publication Date Title
PL241047A1 (en) Method of obtaining immunoenzymatic conjugates
FI93310B (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
ES8604421A1 (es) Un metodo para separar una toxina bacteriana de una muestra biologica
NO872581L (no) Et produksjon av antistoffer ved anvendelse av insolubil iserte immunkomplekser.
DE69000338D1 (de) Expressionssystem zur herstellung von chimaeren monoklonalen antikoerpern.
ATE7761T1 (de) Impfstoff und herstellungsverfahren.
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
ATE162311T1 (de) Immunoassay zum nachweis von kollagen oder kollagenfragmenten
EP0369816A3 (en) Monoclonal antibodies specific for human polymorphic epithelial mucin
FI961439A (fi) Menetelmä terapeuttisesti käyttökelpoisen vasta-aineen tai vasta-ainefragmentin valmistamiseksi
JPS6445398A (en) Antithrombin-binding substance monoclonal antibody, hybridoma producing said antibody and method for purifying and measuring thrombin-binding substance utilizing said monoclonal antibody
ES2056919T3 (es) Anticuerpo monoclonal especifico para la fosfolipasa a2 pancreatica humana.
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
EP0226468A3 (en) Detection of human cancer cells with antibodies to human cancer nucleolar antigen p145
DE3854926D1 (de) Verwendung von antikörper gegen angiogenin: immunotherapeutische mittel
EP0248147A3 (en) Method of determining the presence of cancer cells
ATE86261T1 (de) Tumorassoziiertes antigen.
AU5790390A (en) A novel tumor associated antigen
Gelderblom 3.1 The Preparation and Application of Hybrid Antibody for the Detection of Tumor-Specific Cell Surface Antigens
IT8821547A0 (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.
EP0251186A3 (en) Monoclonal antibody to human plasminogen, method for production thereof, assay reagent and kit comprising said antibody, and hybridoma producing said antibody
JPS6423897A (en) Monoclonal antibody
AU1855900A (en) Anti-petasin antibodies, methods for the production thereof and their use
NO952509L (no) Fremgangsmåte for fremstilling av monoklonale antistoffer eller fragmenter derav